The Apollo University Chittoor B.Pharma {Lateral} : Fees 2026, Course Duration, Dates, Eligibility

Ans. The regular B.Pharma is a 4-year programme (8 semesters) open to students who have passed 10+2 with Physics, Chemistry, and Biology/Mathematics. The B.Pharma Lateral Entry is a 3-year programme (6 semesters, starting from Semester 3) exclusively for D.Pharm holders. Lateral entry students skip the first year entirely and join directly in the 2nd year. The curriculum from Semester 3 onwards is identical for both regular and lateral entry students. The key advantage of lateral entry is that D.Pharm holders can upgrade to a full B.Pharma degree in 3 years instead of starting from scratch, saving one year of study and fees.

Ans. Yes, as per the official TAU website, only 6 seats are available for B.Pharma Lateral Entry at The Apollo University. This makes it extremely competitive. Seats are filled through two routes: Convener Quota (via AP EAPCET Pharmacy stream counselling) and University Quota (merit-based, directly through TAU). Given the very limited seats, candidates are strongly advised to apply early, ensure their AP EAPCET registration is completed before the deadline (24 March 2026 for 2026 admissions), and also apply directly through the university portal to maximise their chances.

Ans. Yes, graduates of the B.Pharma Lateral Entry programme receive the same B.Pharmacy degree as regular students and are fully eligible to pursue M.Pharmacy (2 years) or Pharm.D Post-Baccalaureate (3 years) programmes. For M.Pharmacy, admission is through GPAT (Graduate Pharmacy Aptitude Test) conducted by NTA. For Pharm.D (Post-Baccalaureate), candidates must have completed B.Pharma with at least 50% marks. TAU itself offers the Pharm.D programme, making it convenient for lateral entry graduates to continue their education on the same campus.

Ans. The Practice School (BP706PS) in Semester 7 is a mandatory 12-hour, 6-credit industry internship component where students are placed in pharmaceutical companies, hospitals, or research organisations for hands-on training. For lateral entry students, this falls in their 2nd year of study (which is the 3rd year of the overall B.Pharma programme). Given TAU's affiliation with the Apollo Hospitals Group and its industry connections with companies like Aurobindo Pharma, students have access to quality internship placements. The Practice School is evaluated and graded, contributing to the final degree. Students are advised to confirm placement arrangements with the AIPS placement cell well in advance.

Ans. Yes, D.Pharm holders from any state in India can apply for B.Pharma Lateral Entry at TAU under the University Quota. The University Quota seats are open to all eligible candidates regardless of domicile. However, for Convener Quota seats, candidates typically need to have appeared in AP EAPCET, which is the Andhra Pradesh state-level entrance exam. Candidates from outside AP can still appear in AP EAPCET if they meet the eligibility criteria. Given that only 6 seats are available in total, candidates from outside AP are advised to apply under the University Quota route directly through the TAU admissions portal.

Ans. A B.Pharma degree significantly expands career opportunities compared to a D.Pharm. While D.Pharm holders are primarily eligible for retail pharmacy and hospital dispensing roles, B.Pharma graduates can pursue careers in pharmaceutical manufacturing, quality control and assurance, regulatory affairs, drug formulation and R&D, clinical research, medical sales and marketing, and hospital pharmacy management. B.Pharma is also the minimum qualification required for most pharmaceutical industry roles and for pursuing M.Pharmacy or Pharm.D. Starting salaries for B.Pharma graduates in the pharmaceutical industry typically range from Rs 2.5 to 4.5 LPA, compared to Rs 1.5 to 2.5 LPA for D.Pharm holders in retail pharmacy. The upgrade is particularly valuable for D.Pharm holders already working in the industry who want to move into supervisory or research roles.